Popular Articles
Stretch Mark

Two Day Treatment Of Auditory Hallucinations By High Frequency RTMS Guided By Cerebral Imaging: A 6 Months Follow-up Study
Auditory hallucinations are one of the more disturbing features of schizophrenia, and tend to persist even when patients are treated with conventional medication treatments. Researchers from the University of Caen, France, report on a new treatment for hallucinations at the meeting of the Organization for Human Brain Mapping. They used a technique called Repetitive Transcranial Magnetic Stimulation- rTMS, which sends magnetic pulses at high frequency (20 Hz) over the brain surface. By placing the pulses guided by anatomical and functional cerebral imaging over the auditory cortex where hallucinations are generated, they found a significant reduction in auditory hallucinations that lasted for nearly 2 weeks following the treatment; 2 patients were hallucination free after 6 months. While the study is still preliminary, it suggests the potential for 20 Hz- rTMS as a new, noninvasive approach to treatment of schizophrenia that is relatively safe and free of side effects.
generic viagra online
General Practices Should Carry Out Majority Of Swine Flu Vaccinations
Australia"s general practices stand ready to work with Government to begin vaccinating vulnerable Australians against HINI (Swine Flu) as soon as a vaccine becomes available, the AMA said today.
News of the day
Sensitivity To NNKOAc Is Associated With Renal Cancer Risk
UroToday.com - Cigarette smoking is a major risk factor for renal cell carcinoma (RCC). Cigarette smoke contains a variety of carcinogenic chemicals such as polycyclic aromatic hydrocarbons, aromatic amines, heterocyclic aromatic amines and N-nitrosamines. Among the N-nitrosamines present in cigarette smoke, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is the most abundant and the most potent in terms of carcinogenicity.
Medical Devices

British Medical Journal Examines Recent Progress In Treating Neglected Diseases

The British Medical Journal examines the outcome of the Drugs for Neglected Diseases initiative meeting held in Nairobi, Kenya, last week. More than 200 international health experts came together to discuss finding therapies for such diseases as visceral leishmaniasis, Chagas disease and sleeping sickness. "Current treatments are often toxic, prohibitively expensive, or difficult to administer in countries with limited res," and "[d]rug companies have little incentive to develop treatments for neglected diseases that mainly affect poor people," the journal writes. Developing countries have "the ability to provide new solutions for neglected diseases, but every day we face an uphill battle to find home grown capacity for research and development into diseases that affect our poor," said Monique Wasunna of the Kenya Medical Research Institute, adding, "By working together in regional, needs-driven research platforms, we have been able to do more in the past five years than had been done in the previous 20 years." The article examines the recent progress in the area of neglected diseases research around the world, including new treatment options for disease and partnerships for drug discovery and development (Tanne, 6/29). WHO Experts To Discuss Ways To Fund Neglected Disease Research, Drug Development Intellectual Property Watch explores ways to pay for research and clinical trials for treatments of neglected diseases, "even when the consumer demand is small and [the] constituents poor." The topic will be front and center during a meeting of the Expert Working Group on Research and Development Financing, "which is seen by many governments and nongovernmental organisations as a key outcome of the WHO global strategy and plan of action on public health, innovation and intellectual property" (Mara, 6/29). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):